| 1 |
Kumari R, Rani M, Nigam A, Kumar A. Stem Cell Culture Techniques. Techniques in Life Science and Biomedicine for the Non-Expert 2023. [DOI: 10.1007/978-3-031-19485-6_15] [Reference Citation Analysis]
|
| 2 |
Adefegha SA. Human Embryonic Stem Cells as a Therapy for Alzheimer’s Disease. Handbook of Animal Models and its Uses in Cancer Research 2023. [DOI: 10.1007/978-981-19-3824-5_40] [Reference Citation Analysis]
|
| 3 |
Srivastava R, Li A, Datta T, Jha NK, Talukder S, Jha SK, Chen Z. Advances in stromal cell therapy for management of Alzheimer’s disease. Front Pharmacol 2022;13:955401. [DOI: 10.3389/fphar.2022.955401] [Reference Citation Analysis]
|
| 4 |
Adefegha SA. Human Embryonic Stem Cells as a Therapy for Alzheimer’s Disease. Handbook of Animal Models and its Uses in Cancer Research 2022. [DOI: 10.1007/978-981-19-1282-5_40-1] [Reference Citation Analysis]
|
| 5 |
Anwar MM, Ali OS, Rashed LA, Badawi A, Eltablawy NA. The therapeutic potential and efficiency of Intracerebroventricular transplantation and intravenous injection of Mesenchymal stem cells in relieving Aß hallmarks and improving cognitive dysfunction in AD induced model. Gene Reports 2021;25:101323. [DOI: 10.1016/j.genrep.2021.101323] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Salwa, Kumar L. Engrafted stem cell therapy for Alzheimer's disease: A promising treatment strategy with clinical outcome. J Control Release 2021;338:837-57. [PMID: 34509587 DOI: 10.1016/j.jconrel.2021.09.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 7 |
Srivastava S, Ahmad R, Khare SK. Alzheimer's disease and its treatment by different approaches: A review. Eur J Med Chem 2021;216:113320. [PMID: 33652356 DOI: 10.1016/j.ejmech.2021.113320] [Cited by in Crossref: 59] [Cited by in F6Publishing: 67] [Article Influence: 29.5] [Reference Citation Analysis]
|
| 8 |
Padmakumar S, Taha MS, Kadakia E, Bleier BS, Amiji MM. Delivery of neurotrophic factors in the treatment of age-related chronic neurodegenerative diseases. Expert Opinion on Drug Delivery 2020;17:323-40. [DOI: 10.1080/17425247.2020.1727443] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 9 |
Pereira GC. Governing Issues in Nanoscale Systems and Their Potential for Improving the Therapeutic Application of Phytoconstituents. Plant-derived Bioactives 2020. [DOI: 10.1007/978-981-15-1761-7_24] [Reference Citation Analysis]
|
